Company news

Silence Therapeutics PLC news in 2026

Silence Therapeutics PLC's news releases, calls and decks from 2026, newest first.

View company

Silence Therapeutics Announces Oral Presentation on SANRECO Phase 2 Study of Divesiran in Polycythemia Vera at ASH 2026

November 4, 2026

Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany

October 19, 2026

Decks in 2026